Ashfield Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.25M | Sell |
|
|||||
|
2022
Q2 | $1.2M | Sell |
|
|||||
|
2022
Q1 | $1.72M | Sell |
|
|||||
|
2021
Q4 | $2.39M | Sell |
|
|||||
|
2021
Q3 | $3.17M | Buy |
|
|||||
|
2021
Q2 | $3.25M | Buy |
|
|||||
|
2021
Q1 | $2.43M | Sell |
|
|||||
|
2020
Q4 | $2.65M | Buy |
|
|||||
|
2020
Q3 | $2.04M | Buy |
|
|||||
|
2020
Q2 | $2.05M | Sell |
|
|||||
|
2020
Q1 | $1.7M | Buy |
|
|||||
|
2019
Q4 | $1.82M | Sell |
|
|||||
|
2019
Q3 | $1.88M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.39M | Buy |
|
|||||
|
2018
Q4 | $1.58M | Sell |
|
|||||
|
2018
Q3 | $3.38M | Buy |
|
|||||
|
2018
Q2 | $2.43M | Buy |
|
|||||
|
2018
Q1 | $902K | Buy |
|